Please assess the completion status of the following clinical trial:

Trial Title: RFS (Radiofrequency Stylet) - Radiofrequency Perforator Vein Treatment Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male and female, ages 18 to 80 years, from all racial and ethnic origin~* Have the ability to understand the requirements of the study, provide written informed consent to participate, and agree to abide by the study requirements~* Available for all the follow-up visits and in a physical condition allowing ambulation after the procedure~* Incompetent GSV and/or SSV in the target limb has been treated at least 3 months before study enrollment or competent GSV and SSV at time of treatment~* CEAP 4 - 6 classification~* DUS reflux of ≥0.35 sec or more of the target IPV and/or an intra-fascia diameter of ≥0.3 mm~Exclusion Criteria:~* Acute (at Screening) superficial venous thrombosis of either limb~* Acute (within the prior 3 months) deep venous thrombosis or phlebitis in either limb~* Complete or near complete deep venous obstruction documented by ultrasound~* Previously participated in any study involving ClosureRFS~* Actively participated in any other investigational study within 30 days of enrollment into this study~* Pregnant at the time of treatment. Status verified by pregnancy test via blood or urine for women ≤ 55 years old.~* Having a medical condition, serious intercurrent illness, or extenuating circumstance that would significantly decrease study compliance, including all required study follow-up~* Have any condition that, in the opinion of the Investigator, would jeopardize the safety of the patient or affect the validity of the trial results~* Have a history of excessive alcohol consumption or any use of illegal drugs rendering the patient unreliable, or at risk during this trial~* Have undergone major surgery which may result in abnormalities of the target body area, reasonably suspected to compromise the study outcomes~* Have undergone an invasive procedure of the target body area (e.g., needle biopsy or surgical procedure) within 30 days of enrollment into this study~* Known incompatibility, such as an allergic reaction to anesthetics to be used in the incompetent perforator vein treatment~* Patients requiring hyperbaric therapy involving the treated limb during the 6 month post treatment follow-up period~* Great toe pressure measurement of ≤ 70 mmHg~* CEAP 6 classified patients receiving high dose steroid medication or the following medications that interfere with normal mechanisms of wound healing, e.g. glucocorticoids, non-steroidal anti-inflammatory drugs (NSAIDs), anti-neoplastic and immunosuppressive drugs, and others like, colchicine and penicillamine.~* Expressing a body mass index (BMI) of ≥ 35.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Treatment (Type: OTHER): RF ablation with ClosureRFS Stylet

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues